0001104659-23-059148.txt : 20230511
0001104659-23-059148.hdr.sgml : 20230511
20230511161547
ACCESSION NUMBER: 0001104659-23-059148
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230511
DATE AS OF CHANGE: 20230511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rickard Kathleen A.
CENTRAL INDEX KEY: 0001836883
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 23911241
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4/A
1
tm2315205-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4/A
2023-05-01
2023-05-03
0
0001657312
Verona Pharma plc
VRNA
0001836883
Rickard Kathleen A.
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
0
1
0
0
Chief Medical Officer
1
Ordinary Shares
2023-05-01
4
M
0
15000
A
2986136
D
Restricted Share Units
2023-05-01
4
M
0
15000
0.00
D
2029-03-29
Ordinary Shares
15000
0
D
Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
Each Restricted Share Unit represented a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria.
Consists of (i) 1,743,488 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which are represented by 217,936 ADSs); and (ii) 1,242,648 Ordinary Shares underlying 155,331 ADSs.
This Form 4/A is being filed to report the vesting of certainly previously reported Restricted Share Units which was inadvertently omitted in the Form 4 filed on May 3, 2023. The aggregate total in column 5 of Table I hereof reflects the total aggregate holdings after accounting for the sales reported in the Form 4 filed on May 3, 2023.
/s/ Claire Poll, Attorney-in-fact for Kathleen A. Rickard
2023-05-11